UK health agency starts study of PFAS and other chemical exposure
UKHSA plans to analyze existing survey samples to establish baseline chemical exposure levels, with initial findings expected in 2027.
What the record says
The UK Health Security Agency announced a human biomonitoring study November 3 to improve understanding of exposure to PFAS and other chemicals. Researchers will analyze blood and urine samples collected through Health Survey England. Alongside PFAS, the work will measure lead, arsenic, bisphenols, phthalates and flame retardants. The aim is to establish background exposure levels and support further research. Initial findings are expected in 2027. UKHSA says important gaps remain in understanding what particular exposure levels mean for an individual’s long-term health. It is not currently recommending routine PFAS blood testing and says there is no established clinical intervention tied to a specific PFAS blood level.
Source details and supporting locations.
Practical next step
Read UKHSA’s announcement for the study’s scope. People concerned about their health can seek advice from their healthcare professional, as the agency recommends.
Limits and what is not established
The announced research has not yet produced its initial findings. Detecting a chemical does not by itself establish a health outcome or an appropriate treatment.
Sources checked November 4, 2026. Later notices may change instructions or arrangements.
Original sources
UK Health Security Agency: original information